Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?

Gynecological Endocrinology

Volumn 29, Issue 11, 2013, Pages 993-996

  Revelli, A ^a   Porcu, E ^b   Levi Setti, P E ^c   Delle Piane, L ^a,c   Merlo, D F ^d   Anserini, P ^d  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Breast cancer; Fertility preservation; Gonadotropins; Letrozole; Oocyte cryostorage

Indexed keywords

ESTROGEN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; COHORT ANALYSIS; CRYOPRESERVATION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPRODUCTIVE PROCEDURE; RETROSPECTIVE STUDY;

ADULT; ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; BREAST NEOPLASMS; COHORT STUDIES; CRYOPRESERVATION; ESTRADIOL; FEMALE; FERTILITY PRESERVATION; GONADOTROPINS; HUMANS; ITALY; NEOPLASM PROTEINS; NITRILES; OOCYTE RETRIEVAL; OOCYTES; OOGENESIS; OVULATION INDUCTION; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; TRIAZOLES; UP-REGULATION;

EID: 84885072356     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.819083     Document Type: Article

References (29)

1. Rodriguez-Wallberg KA, Oktay K. Fertility preservation in women with breast cancer. Clin Obstet Gynecol 2010; 53: 753-62.
2. Sonmezer M, Oktay K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist 2006; 11: 422-34.
3. Revelli A, Molinari E, Salvagno F, et al. Oocyte cryostorage to preserve fertility in oncological patients. Obstet Gynecol Int 2012; 2012: 525896.
4. Boldt J. Current results with slow freezing and vitrification of the human oocyte. Reprod Biomed Online 2011; 23: 314-22.
5. ISFP Practice Committee, Kim SS, Donnez J, et al. Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet 2012; 29: 465-8.
6. Azim A, Oktay K. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil Steril 2007; 88: 657-64.
7. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 2008; 26: 2630-5.
8. Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006; 91: 3885-90.
9. Ben-Haroush A, Farhi J, Ben-Aharon I, et al. High yield of oocytes without an increase in circulating estradiol levels in breast cancer patients treated with follicle-stimulating hormone and aromatase inhibitor in standard gonadotropin-releasing hormone analogue protocols. Isr Med Assoc J 2011; 13: 753-6.
10. Badawy A, Abdel Aal I, Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril 2009; 92: 849-52.
11. Badawy A, Mosbah A, Tharwat A, Eid M. Extended letrozole therapy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a novel protocol. Fertil Steril 2009; 92: 236-9.
12. Verpoest WM, Kolibianakis E, Papanikolaou E, et al. Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reprod Biomed Online 2006; 13: 166-72.
13. Papanikolaou EG, Polyzos NP, Humaidan P, et al. Aromatase inhibitors in stimulated IVF cycles. Reprod Biol Endocrinol 2011; 9: 85.
14. Requena A, Herrero J, Landeras J, et al. Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update 2008; 14: 571-82.
15. Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005; 23: 4347-53.
16. Edgar DH, Gook DA. A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum Reprod Update 2012; 18: 536-54.
17. Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol 2005; 23: 3858-9.
18. Oktay K, Buyuk E, Akar Z, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. Fertil Steril 2004; 82: s1.
19. Checa Vizca?no MA, Corchado AR, Sastre I, et al. The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women. Reprod Biomed Online 2012; 24: 606-10.
20. Levi Setti PE, Albani E, Novara PV, et al. Cryopreservation of supernumerary oocytes in IVF/ICSI cycles. Hum Reprod 2006; 21: 370-5.
21. Borini A, Levi Setti PE, Anserini P, et al. Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome. Fertil Steril 2010; 94: 1662-8.
22. Porcu E, Fabbri R, Damiano G, et al. Oocyte cryopreservation in oncological patients. Eur J Obstet Gynecol Reprod Biol 2004; 113: S14-6.
23. Porcu E, Venturoli S, Damiano G, et al. Healthy twins delivered after oocyte cryopreservation and bilateral ovariectomy for ovarian cancer. Reprod BioMed Online 2008; 17: 265-267.
24. Porcu E, Ciotti MP, Venturoli S. Handbook of human oocyte cryopreservation. Cambridge, UK: Cambridge University Press; 2012.
25. Lee S, Oktay K. Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer? Fertil Steril 2012; 98: 961-4.
26. Domingo J, Guillen V, Ayllon Y, et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril 2012; 97: 930-4.
27. Almog B, Azem F, Gordon D, et al. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation. Fertil Steril 2012; 98: 957-60.
28. Germain D. Estrogen carcinogenesis in breast cancer. Endocrinol Metab Clin North Am 2011; 40: 473-84.
29. Chang M. Dual roles of estrogen metabolism in mammary carcinogenesis. BMB Rep 2011; 44: 423-34.